Volume 11, Number 4—April 2005
Dispatch
Ross River Virus Disease Reemergence, Fiji, 2003–2004
Table
IgM results† |
PRNT titers‡ |
|||||
---|---|---|---|---|---|---|
Patient | Interval (d)§ | RRV | BFV | RRV | BFV | SINV |
1 | 10 | Positive | Negative | 320 | <10 | <10 |
21 | Positive | Negative | 1,280 | <10 | <10 | |
141 | Equivocal | Negative | 160 | ND | ND | |
2 | 16 | Positive | Negative | 5,120 | <10 | ND |
33 | Positive | Negative | 5,120 | <10 | ND |
*Ig, immunoglobulin; PRNT, plaque-reduction neutralization test; RRV, Ross River virus; BFV, Barmah Forest virus; SINV, Sindbis virus; ND, not done.
†IgM-capture enzyme immunoassay; samples tested at 1:400 dilution; positive samples had a positive-to-negative (P/N) absorbance ratio >3.0; equivocal samples had a P/N ratio 2.0–3.0 (10); no test for anti-SINV IgM was available.
‡90% plaque-reduction endpoints; >10 is considered positive (11).
§From onset of illness to serum collection.
References
- Russell RC. Ross River virus ecology and distribution. Annu Rev Entomol. 2002;▪▪▪:471–31.PubMedGoogle Scholar
- Harley D, Sleigh A, Ritchie S. Ross River virus transmission, infection, and disease: cross-disciplinary review. Clin Microbiol Rev. 2001;14:909–32. DOIPubMedGoogle Scholar
- Australian Government, Department of Health and Ageing. Communicable disease surveillance. Highlights for 1st quarter, 2004. Commun Dis Intell. 2004;28:281–99.PubMedGoogle Scholar
- Aaskov JG, Mataika JU, Lawrence GW, Rabukawaqa V, Tucker MM, Miles JA, An epidemic of Ross River virus infection in Fiji, 1979. Am J Trop Med Hyg. 1981;30:1053–9.PubMedGoogle Scholar
- Tesh RB, McLean RG, Shroyer DA, Calisher CH, Rosen L. Ross River virus (Togaviridae: Alphavirus) infection (epidemic polyarthritis) in American Samoa. Trans R Soc Trop Med Hyg. 1981;75:426–31. DOIPubMedGoogle Scholar
- Rosen L, Gubler DJ, Bennett PH. Epidemic polyarthritis (Ross River) virus infection in the Cook Islands. Am J Trop Med Hyg. 1981;30:1294–302.PubMedGoogle Scholar
- Marshall ID, Miles JAR. Ross River virus and epidemic polyarthritis. In: Harris KF, editor. Current topics in vector research. New York: Praeger; 1984. p. 31–56.
- Kay BH, Aaskov JG. Ross River virus (epidemic polyarthritis). In: Monath TP, editor. The arboviruses: epidemiology and ecology, vol IV. Boca Raton (FL): CRC Press; 1989. p. 93–112.
- Proll S, Dobler G, Pfeffer M, Jelinek T, Nothdurft HD, Loscher T. Persistent arthralgias in Ross-River-virus disease after travel to the South Pacific [article in German]. Dtsch Med Wochenschr. 1999;124:759–62.PubMedGoogle Scholar
- Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol. 2000;38:1823–6.PubMedGoogle Scholar
- Beaty BJ, Calisher CH, Shope RE. Arboviruses. In: Lennette EH, Lennette DA, Lennette ET, editors. Diagnostic procedures for viral, rickettsial, and chlamydial infections. 7th ed. Washington: American Public Health Association; 1995. p. 189–212.
- Messer WB, Gubler DJ, Harris E, Sivananthan K, de Silva AM. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis. 2003;9:800–9.PubMedGoogle Scholar
- Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. West Nile virus. Lancet Infect Dis. 2002;2:519–29. DOIPubMedGoogle Scholar
- Hueston L, Yund A, Cope S, Monteville M, Marchetti M, Haniotis J, Ross River virus in a joint military exercise. Commun Dis Intell. 1997;21:193.PubMedGoogle Scholar
- Kelly-Hope LA, Purdie DM, Kay BH. Risk of mosquito-borne epidemic polyarthritis disease among international visitors to Queensland, Australia. J Travel Med. 2002;9:211–3. DOIPubMedGoogle Scholar
- Kelly-Hope LA, Kay BH, Purdie DM, Williams GM. The risk of Ross River and Barmah Forest virus disease in Queensland: implications for New Zealand. Aust N Z J Public Health. 2002;26:69–77. DOIPubMedGoogle Scholar
Page created: May 23, 2011
Page updated: May 23, 2011
Page reviewed: May 23, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.